New Delhi, Jan. 14 -- Pee Safe, a personal hygiene brand, plans to expand its offline and online presence after raising $32 million ( Rs.290 crore) from global healthcare-focused private equity firm O... Read More
New Delhi, Jan. 6 -- Dear reader, as 2025, a year of global tumult and volatility, rolls by, Mint's reporters and columnists look around the corner on what is coming in 2026-to help you know what to e... Read More
New Delhi, Jan. 2 -- The growing popularity of obesity drugs is expected to spur Indian pharma companies to sign licensing partnerships and distribution deals as they eye the lucrative segment. Indian... Read More
New Delhi, Dec. 19 -- Pfizer India and Cipla announced a partnership on Friday in which Cipla will exclusively market and distribute four Pfizer brands in India to increase their reach. These include... Read More
New Delhi, Dec. 16 -- Even as large hospitals in India rapidly consolidate, smaller corporate chains are aggressively expanding with an aim to grow into regional leaders - which, experts say, in turn,... Read More
MUMBAI, Dec. 13 -- Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of Rs.2,200 per week. For a four-week course, the entry 0.25 m... Read More
MUMBAI, Dec. 13 -- Danish drugmaker Novo Nordisk on Friday launched its blockbuster diabetes drug Ozempic in India, with a starting price of Rs.2,200 per week. For a four-week course, the entry 0.25 m... Read More
MUMBAI, Dec. 12 -- Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday, pricing the entry 0.25 mg dose at Rs.8,800 for a four-week course. The launch comes ... Read More
MUMBAI, Dec. 12 -- Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday, with a headline starting price of Rs.2,200 per week. For a four-week course, the ent... Read More
New Delhi, Dec. 10 -- French pharmaceutical group Servier is sharpening its India strategy with a string of new oncology launches focused on rare cancers, plans for local manufacturing of active ingre... Read More